BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 27795339)

  • 1. Prospective Biomarker Screening for Diagnosis of Invasive Aspergillosis in High-Risk Pediatric Patients.
    Loeffler J; Hafner J; Mengoli C; Wirth C; Heussel CP; Löffler C; White PL; Ullmann AJ; Michel D; Wiegering V; Wölfl M; Schlegel PG; Einsele H; Springer J; Eyrich M
    J Clin Microbiol; 2017 Jan; 55(1):101-109. PubMed ID: 27795339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
    Aydoğan S; Kuştimur S; Kalkancı A
    Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients.
    Armenian SH; Nash KA; Kapoor N; Franklin JL; Gaynon PS; Ross LA; Hoffman JA
    J Pediatr Hematol Oncol; 2009 Dec; 31(12):920-6. PubMed ID: 19855303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of circulating Aspergillus fumigatus DNA by real-time PCR assay of large serum volumes improves early diagnosis of invasive aspergillosis in high-risk adult patients under hematologic surveillance.
    Suarez F; Lortholary O; Buland S; Rubio MT; Ghez D; Mahé V; Quesne G; Poirée S; Buzyn A; Varet B; Berche P; Bougnoux ME
    J Clin Microbiol; 2008 Nov; 46(11):3772-7. PubMed ID: 18845828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies.
    Florent M; Katsahian S; Vekhoff A; Levy V; Rio B; Marie JP; Bouvet A; Cornet M
    J Infect Dis; 2006 Mar; 193(5):741-7. PubMed ID: 16453271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribosomal and mitochondrial DNA target for real-time PCR diagnosis of invasive aspergillosis.
    Millon L; Grenouillet F; Legrand F; Loewert S; Bellanger AP; Gbaguidi-Haore H; Scherer E; Henon T; Rohrlich P; Deconinck E
    J Clin Microbiol; 2011 Mar; 49(3):1058-63. PubMed ID: 21227993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of polymerase chain reaction and galactomannan for the diagnosis of invasive aspergillosis in patients with febrile neutropenia.
    Aslan M; Oz Y; Aksit F; Akay OM
    Mycoses; 2015 Jun; 58(6):343-9. PubMed ID: 25851634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time PCR on the first galactomannan-positive serum sample for diagnosing invasive aspergillosis in liver transplant recipients.
    Botterel F; Farrugia C; Ichai P; Costa JM; Saliba F; Bretagne S
    Transpl Infect Dis; 2008 Oct; 10(5):333-8. PubMed ID: 18627580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.
    Eigl S; Hoenigl M; Spiess B; Heldt S; Prattes J; Neumeister P; Wolfler A; Rabensteiner J; Prueller F; Krause R; Reinwald M; Flick H; Buchheidt D; Boch T
    Med Mycol; 2017 Jul; 55(5):528-534. PubMed ID: 27744310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Aspergillus-specific PCR as a screening method for invasive aspergillosis in paediatric cancer patients and allogeneic haematopoietic stem cell recipients with suspected infections.
    Reinwald M; Konietzka CA; Kolve H; Uhlenbrock S; Ahlke E; Hummel M; Spiess B; Hofmann WK; Buchheidt D; Groll AH
    Mycoses; 2014 Sep; 57(9):537-43. PubMed ID: 24655146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of PCR-ELISA and galactomannan detection for the diagnosis of invasive aspergillosis.
    Scotter JM; Campbell P; Anderson TP; Murdoch DR; Chambers ST; Patton WN
    Pathology; 2005 Jun; 37(3):246-53. PubMed ID: 16175901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis.
    White PL; Parr C; Thornton C; Barnes RA
    J Clin Microbiol; 2013 May; 51(5):1510-6. PubMed ID: 23486712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan.
    Mikulska M; Furfaro E; De Carolis E; Drago E; Pulzato I; Borghesi ML; Zappulo E; Raiola AM; Grazia CD; Del Bono V; Cittadini G; Angelucci E; Sanguinetti M; Viscoli C
    Med Mycol; 2019 Nov; 57(8):987-996. PubMed ID: 30753590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of MycAssay Aspergillus DNA real-time PCR assay compared with the galactomannan detection assay for the diagnosis of invasive aspergillosis from serum samples.
    Danylo A; Courtemanche C; Pelletier R; Boudreault AA
    Med Mycol; 2014 Aug; 52(6):577-83. PubMed ID: 25023484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial.
    Aguado JM; Vázquez L; Fernández-Ruiz M; Villaescusa T; Ruiz-Camps I; Barba P; Silva JT; Batlle M; Solano C; Gallardo D; Heras I; Polo M; Varela R; Vallejo C; Olave T; López-Jiménez J; Rovira M; Parody R; Cuenca-Estrella M; ; ; ;
    Clin Infect Dis; 2015 Feb; 60(3):405-14. PubMed ID: 25336623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Galactomannan Antigen and Aspergillus DNA Real-time Polymerase Chain Reaction as Routine Methods for Invasive Aspergillosis in Immunosuppressed Children in Greece.
    Vrioni G; Theodoridou K; Tsiamis C; Mavrouli M; Kapsimali V; Rigopoulos D; Tsakris A
    Clin Ther; 2018 Jun; 40(6):918-924.e2. PubMed ID: 29807668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis.
    Boch T; Buchheidt D; Spiess B; Miethke T; Hofmann WK; Reinwald M
    Mycoses; 2016 Feb; 59(2):80-5. PubMed ID: 26627577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Not Available].
    Hedhili S; Baccouchi N; Souid H; Jemli B; Gargouri S
    J Mycol Med; 2017 Dec; 27(4):487-493. PubMed ID: 28822706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies.
    Rogers TR; Morton CO; Springer J; Conneally E; Heinz W; Kenny C; Frost S; Einsele H; Loeffler J
    Br J Haematol; 2013 May; 161(4):517-24. PubMed ID: 23614624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspergillus PCR in serum for the diagnosis, follow-up and prognosis of invasive aspergillosis in neutropenic and nonneutropenic patients.
    Imbert S; Gauthier L; Joly I; Brossas JY; Uzunov M; Touafek F; Brun S; Mazier D; Datry A; Gay F; Fekkar A
    Clin Microbiol Infect; 2016 Jun; 22(6):562.e1-8. PubMed ID: 26899830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.